Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Savvy Nutricosmetics Marketing Could Spur U.S. Uptake

This article was originally published in The Tan Sheet

Executive Summary

U.S. consumers have been slow to embrace nutricosmetics as part of a beauty regimen, but marketers’ efforts are paying off, industry experts say. Consumers are warming to nutricosmetics as scientific evidence emerges to back up claims and bring credibility to ingredients, says JJMD Skincare President Jeanette Jacknin.

You may also be interested in...



Hawaii Puts Hold On Proposal To Blacklist Additional Sunscreen Ingredients

Proposed bills in the Aloha State would ban the sale of sunscreens containing octocrylene and/or avobenzone, adding to a UV filter blacklist that already includes oxybenzone and octinoxate. On 17 February, Hawaiian legislators elected to defer the legislation to await completion of a National Academy of Sciences study, targeted for 2022.

COVID Spells ‘The End Of Influencers’? Not Remotely, But The Game Is Changing

Market analysts and forecasters discuss the evolving role of influencers, which COVID-19 has affected like virtually everything else.

California Air Board Projects $210m In 15-Year Costs For Personal-Care VOC Compliance

Years in the making, California is close to adopting updated volatile organic compound limits for selected personal-care products under the state’s Consumer Products Regulation. The Air Resources Board is accepting comments ahead of a 25 March hearing to consider approving the amendments for adoption.

Topics

UsernamePublicRestriction

Register

LL1135424

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel